Latest Updates

Ethical Considerations for a COVID-19 Vaccine Mandate

Mandate to vaccinate or nudge if there is no budge? COVID-19 vaccines remain a key weapon in the fight against the deadliest modern-day pandemic the world has seen. In this article, we summarize key facts and ethical considerations for healthcare organizations when considering a COVID-19 vaccine mandate for U.S. healthcare workers (HCW).

Posted: 6/17/2021 | 0 comments | Coronavirus, COVID-19, Ethics, Vaccines

Concise Critical Appraisal: Cardiac Ultrasound in Pediatric Septic Shock Assessment
How can clinical information gleaned from focused cardiac ultrasound (FCU) be used to augment clinical assessments in children with suspected septic shock? This month’s Concise Critical Appraisal analyzes a study published in Pediatric Critical Care Medicine that sought to show how often a clinician’s hemodynamic characterization of a child with septic shock was altered by FCU and to further validate an expert-developed algorithm for these assessments.
Posted: 6/10/2021 | 0 comments | Concise Critical Appraisal, pediatrics, Septic Shock, Ultrasound

An SCCM Member Responds to a Call for Volunteers
Before the COVID-19 pandemic, Tina R. Shah, MD, MPH, focused her work on two questions: How can technology help improve the United States health system and, more specifically, how can it be used to improve patient and practitioner well-being?
Posted: 6/4/2021 | 0 comments | COVID-19, COVID-19 Calls for Volunteers, COVID-19 Member Stories

Concise Critical Appraisal: Development of the CCEeXAM
Bedside echocardiography has become increasingly widespread among physicians caring for critically ill patients. The Examination of Special Competence in Critical Care Echocardiography (CCEeXAM) was administered for the first time in 2019 to 524 physicians from multiple specialties. The examination was designed for physicians to demonstrate an objective competence and obtain certification in advanced critical care echocardiography (CCE).
Posted: 5/13/2021 | 0 comments | Concise Critical Appraisal, Echocardiography

Johnson & Johnson’s Janssen COVID-19 Vaccine: What Clinicians Need to Know
In the past few weeks more than 7 million doses of Johnson & Johnson’s Janssen COVID-19 vaccine have been administered to people in the United States. In clinical trials of approximately 40,000 people, the J&J vaccine given as a single shot was 66% effective at preventing the illness due to the SARS-CoV-2 virus known as COVID-19. Because the J&J vaccine is a single shot, it has been preferred in some circumstances.
Posted: 4/16/2021 | 0 comments | Coronavirus, COVID-19, Vaccines